Turn Therapeutics Inc. (TTRX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US90021W1053
Turn Therapeutics Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -5.86 m USD |
| EBIT | -3.22 m USD |
| Net income | -3.19 m USD |
| Diluted EPS – continuing operations | -0.12 USD |
Full history since 2023, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Turn Therapeutics Inc.
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
More stocks
- Hynar Water Group Co. Ltd. (300961.SZ)
- Bsm Chemical Co Ltd (300796.SZ)
- Cogeco Inc. (CGO.TO)
- Surgical Science Sweden AB (SUS.ST)
- DONGKUK STEEL MILL CLS LTD (460860.KS)
- Know IT AB (KNOW.ST)
- COMMUNITY HEALTH SYSTEMS INC (CYH)
- Hanyang ENG Co. Ltd (045100.KQ)
- Taewoong Co.Ltd (044490.KQ)
- KG Mobility Corp. (003620.KS)
- SmartRent, Inc. (SMRT)
- TienPin United Enterprise CO., LTD. (6199.TWO)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.